Literature DB >> 30039904

A genome-wide analysis of colorectal cancer in a child with Noonan syndrome.

Rahul M Prasad1,2, Rajen J Mody2, George Myers3, Melisa Mullins3, Zaher Naji3, James D Geiger4.   

Abstract

Noonan syndrome (NS) is a developmental syndrome caused by germline mutations in the Ras signaling pathway. No association has been shown between NS and pediatric colorectal cancer (CRC). We report the case of CRC in a pediatric patient with NS. The patient underwent whole genome sequencing. A germline SOS1 mutation c.1310T>C (p. Ile437Thr) confirmed NS diagnosis. No known hereditary cancer syndromes were identified. Tumor analysis revealed two mutations: a TP53 missense mutation c.481G>A (p. Ala161Tyr) and NCOR1 nonsense mutation c.6052C>T (p. Arg2018*). This report highlights the complexity of Ras signaling and the interplay between developmental syndromes and cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Noonan syndrome; molecular genetics; pediatric hematology/oncology; rare tumors; solid; tumors

Mesh:

Substances:

Year:  2018        PMID: 30039904      PMCID: PMC6150814          DOI: 10.1002/pbc.27362

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  20 in total

Review 1.  Developmental disease and cancer: biological and clinical overlaps.

Authors:  Alfonso Bellacosa
Journal:  Am J Med Genet A       Date:  2013-10-07       Impact factor: 2.802

2.  Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.

Authors:  Christian P Kratz; Suthee Rapisuwon; Helen Reed; Henrik Hasle; Philip S Rosenberg
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-15       Impact factor: 3.908

Review 3.  Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.

Authors:  Madeline M Wong; Chun Guo; Jinsong Zhang
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

Review 4.  Hyperactive Ras in developmental disorders and cancer.

Authors:  Suzanne Schubbert; Kevin Shannon; Gideon Bollag
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

5.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Authors:  Matthew B Yurgelun; Serena Masciari; Victoria A Joshi; Rowena C Mercado; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins; Daniel D Buchanan; Polly A Newcomb; John D Potter; Robert W Haile; Raju Kucherlapati; Sapna Syngal
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

Review 6.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.

Authors:  John M Carethers; Barbara H Jung
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

7.  Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

Authors:  Akihiro Fujimoto; Mayuko Furuta; Yasushi Totoki; Tatsuhiko Tsunoda; Mamoru Kato; Yuichi Shiraishi; Hiroko Tanaka; Hiroaki Taniguchi; Yoshiiku Kawakami; Masaki Ueno; Kunihito Gotoh; Shun-Ichi Ariizumi; Christopher P Wardell; Shinya Hayami; Toru Nakamura; Hiroshi Aikata; Koji Arihiro; Keith A Boroevich; Tetsuo Abe; Kaoru Nakano; Kazuhiro Maejima; Aya Sasaki-Oku; Ayako Ohsawa; Tetsuo Shibuya; Hiromi Nakamura; Natsuko Hama; Fumie Hosoda; Yasuhito Arai; Shoko Ohashi; Tomoko Urushidate; Genta Nagae; Shogo Yamamoto; Hiroki Ueda; Kenji Tatsuno; Hidenori Ojima; Nobuyoshi Hiraoka; Takuji Okusaka; Michiaki Kubo; Shigeru Marubashi; Terumasa Yamada; Satoshi Hirano; Masakazu Yamamoto; Hideki Ohdan; Kazuaki Shimada; Osamu Ishikawa; Hiroki Yamaue; Kazuki Chayama; Satoru Miyano; Hiroyuki Aburatani; Tatsuhiro Shibata; Hidewaki Nakagawa
Journal:  Nat Genet       Date:  2016-04-11       Impact factor: 38.330

8.  SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.

Authors:  Kenneth D Swanson; Jordan M Winter; Marcelo Reis; Mohamed Bentires-Alj; Heidi Greulich; Rupinder Grewal; Ralph H Hruban; Charles J Yeo; Yosuf Yassin; Oleg Iartchouk; Kate Montgomery; Susan P Whitman; Michael A Caligiuri; Mignon L Loh; D Gary Gilliland; A Thomas Look; Raju Kucherlapati; Scott E Kern; Matthew Meyerson; Benjamin G Neel
Journal:  Genes Chromosomes Cancer       Date:  2008-03       Impact factor: 5.006

9.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

10.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.